269 related articles for article (PubMed ID: 38792060)
1. Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.
Lin C; Tian Q; Guo S; Xie D; Cai Y; Wang Z; Chu H; Qiu S; Tang S; Zhang A
Molecules; 2024 May; 29(10):. PubMed ID: 38792060
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
Luan H; Wang X; Cai Z
Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
Zhang A; Sun H; Yan G; Wang P; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
[TBL] [Abstract][Full Text] [Related]
5. FUNCTIONAL METABOLOMICS DECIPHER BIOCHEMICAL FUNCTIONS AND ASSOCIATED MECHANISMS UNDERLIE SMALL-MOLECULE METABOLISM.
Hu L; Liu J; Zhang W; Wang T; Zhang N; Lee YH; Lu H
Mass Spectrom Rev; 2020 Sep; 39(5-6):417-433. PubMed ID: 31682024
[TBL] [Abstract][Full Text] [Related]
6. Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence.
Wang XJ; Ren JL; Zhang AH; Sun H; Yan GL; Han Y; Liu L
Mass Spectrom Rev; 2019 Aug; 38(4-5):380-402. PubMed ID: 30817039
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
Zhao LK; Zhao YB; Yu PC; Zhang PX
Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
[TBL] [Abstract][Full Text] [Related]
8. High-throughput metabolomics for discovering metabolic biomarkers from intestinal tumorigenesis in APC
Guo XD; Liu L; Xiao HY
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():131-139. PubMed ID: 30316137
[TBL] [Abstract][Full Text] [Related]
9. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
[TBL] [Abstract][Full Text] [Related]
10. UPLC-G2Si-HDMS untargeted metabolomics for identification of metabolic targets of Yin-Chen-Hao-Tang used as a therapeutic agent of dampness-heat jaundice syndrome.
Sun H; Yang L; Li MX; Fang H; Zhang AH; Song Q; Liu XY; Su J; Yu MD; Makino T; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():41-50. PubMed ID: 29502028
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
12. Small molecule metabolites: discovery of biomarkers and therapeutic targets.
Qiu S; Cai Y; Yao H; Lin C; Xie Y; Tang S; Zhang A
Signal Transduct Target Ther; 2023 Mar; 8(1):132. PubMed ID: 36941259
[TBL] [Abstract][Full Text] [Related]
13. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
Buck A; Aichler M; Huber K; Walch A
Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
[TBL] [Abstract][Full Text] [Related]
15. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry.
Fang H; Zhang AH; Sun H; Yu JB; Wang L; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():112-120. PubMed ID: 30743140
[TBL] [Abstract][Full Text] [Related]
16. Challenges in mass spectrometry based targeted metabolomics.
Koal T; Deigner HP
Curr Mol Med; 2010 Mar; 10(2):216-26. PubMed ID: 20196726
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in infectious diseases and drug discovery.
Tounta V; Liu Y; Cheyne A; Larrouy-Maumus G
Mol Omics; 2021 Jun; 17(3):376-393. PubMed ID: 34125125
[TBL] [Abstract][Full Text] [Related]
18. Applications of metabolomics in drug discovery and development.
Wishart DS
Drugs R D; 2008; 9(5):307-22. PubMed ID: 18721000
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics, pathway regulation, and pathway discovery.
Zhang GF; Sadhukhan S; Tochtrop GP; Brunengraber H
J Biol Chem; 2011 Jul; 286(27):23631-5. PubMed ID: 21566142
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
